Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594953 | SCV000702800 | pathogenic | not provided | 2016-11-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000594953 | SCV001393870 | pathogenic | not provided | 2024-12-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp782*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Stargardt disease (PMID: 23143460, 27874104, 29114839). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 498001). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005027700 | SCV005659573 | pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-06-11 | criteria provided, single submitter | clinical testing |